United Therapeutics Corporation

United Therapeutics Corporation

World Rank (Aug-2026)
1175
Market Cap (Aug-2026)
21.434 Billion USD
World Rank (Jan-05-2024)
1,546
Market Cap (Jan-05-2024)
10.814 Billion USD
World Rank (Jul-30-2023)
1,503
Market Cap (Jul-30-2023)
11.487 Billion USD
World Rank (Jan-07-2022)
2,048
Market Cap (Jan-07-2022)
8.960 Billion USD
World Rank (Jan-01-2021)
2,318
Market Cap (Jan-01-2021)
6.746 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 570
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
UTHR
Employee Count
985
Employee Count as of Date
As on 2022
Headquarters City/State
Maryland
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
3,183 Million USD
Annual Operating Income in USD
1,493 Million USD
Annual Net Income in USD
1,335 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
7,880 Million USD
Total Liabilities in USD
784 Million USD
Total Equity in USD
7,096 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
UNITED THERAPEUTICS CORPORATION
Yahoo
Yahoo @ Nasdaq
Company Profile

United Therapeutics Corporation is a Biotechnology company. The headquarters is in USA.

United Therapeutics Corporation total number of employees in 2022 was 985.

United Therapeutics Corporation annual revenue generated for period ending Dec-2022 was 1,936 million USD.

United Therapeutics Corporation annual net income generated for period ending Dec-2022 was 727 million USD.

Annual Results Summary

UNITED THERAPEUTICS CORPORATION - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueGross IncomeOperating IncomeNet Income
Dec-20221,9361,784979727
Dec-20211,6851,563555475
Dec-20201,4831,375593514
Dec-20191,4481,331-187 (Loss)-104 (Loss)
Dec-20181,6271,429805589
Balance Sheet Summary

Total Assets as on Dec-2022 was 6,044 Million USD.

Total Liabilities as on Dec-2022 was 1,247 Million USD.

Total Equity as on Dec-2022 was 4,796 Million USD.

Founded Year
1996
IPO Year
1999
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share